Design at the atomic level: Generation of novel hybrid biaryloxazolidinones as promising new antibiotics

被引:35
|
作者
Zhou, Jiacheng [2 ]
Bhattacharjee, Ashoke [2 ]
Chen, Shili [2 ]
Chen, Yi [2 ]
Duffy, Erin [1 ]
Farmer, Jay [2 ]
Goldberg, Joel [2 ]
Hanselmann, Roger [2 ]
Ippolito, Joseph A. [1 ]
Lou, Rongliang [2 ]
Orbin, Alia [2 ]
Oyelere, Ayomi [2 ]
Salvino, Joe [2 ]
Springer, Dane [2 ]
Tran, Jennifer [2 ]
Wang, Deping [1 ]
Wu, Yusheng [2 ]
Johnson, Graham [1 ,2 ]
机构
[1] Rib X Pharmaceut Inc, Dept Struct Based Drug Design, New Haven, CT 06511 USA
[2] Rib X Pharmaceut Inc, Dept Med Chem, New Haven, CT 06511 USA
关键词
Oxazolidinone; Biaryloxazolidinone; Structure-based drug design; Linezolid; Sparsomycin; Gram-negative bacteria; X-ray crystal structure; Ribosome; Oral antibiotics; Hybrid antibiotics;
D O I
10.1016/j.bmcl.2008.10.014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
From the X-ray crystal structures of linezolid and the non-selective antibiotic sparsomycin, we have derived a new family of hybrid oxazolidinones. From this initial compound set we have developed a new biaryloxazolidinone scaffold that shows both potent antimicrobial activity as well as selective inhibition of ribosomal translation. The synthesis of these compounds is outlined. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6179 / 6183
页数:5
相关论文
共 50 条
  • [1] Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics
    Zhou, Jiacheng
    Bhattacharjee, Ashoke
    Chen, Shili
    Chen, Yi
    Duffy, Erin
    Farmer, Jay
    Goldberg, Joel
    Hanselmann, Roger
    Ippolito, Joseph A.
    Lou, Rongliang
    Orbin, Alia
    Oyelere, Ayomi
    Salvino, Joe
    Springer, Dane
    Tran, Jennifer
    Wang, Deping
    Wu, Yusheng
    Johnson, Graham
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6175 - 6178
  • [2] Novel assays and novel strains - promising routes to new antibiotics?
    Donadio, Stefano
    Brandi, Letizia
    Monciardini, Paolo
    Sosio, Margherita
    Gualerzi, Claudio O.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (06) : 789 - 798
  • [3] Design of dual action antibiotics as an approach to search for new promising drugs
    Tevyashova, A. N.
    Olsufyeva, E. N.
    Preobrazhenskaya, M. N.
    [J]. RUSSIAN CHEMICAL REVIEWS, 2015, 84 (01) : 61 - 97
  • [4] Using a novel hybrid method for the design of a new class of antibiotics to target DnaG primase of Mycobacterium tuberculosis
    Ilic, S.
    Singh, M.
    Dayan, A.
    Tam, B.
    Akabayov, B.
    [J]. FEBS JOURNAL, 2017, 284 : 97 - 97
  • [5] Design, Synthesis, and Evaluation of Novel Fluoroquinolone-Aminoglycoside Hybrid Antibiotics
    Pokrovskaya, Varvara
    Belakhov, Valery
    Hainrichson, Mariana
    Yaron, Sima
    Baasov, Timor
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2243 - 2254
  • [6] Aromatic Phosphinous Amides: A Promising New Generation of Antibiotics for Multidrug-Resistant Bacterial Infections
    Irshaid, Fawzi Irshaid
    Eshawakh, Samia Ramadan
    Hunaiti, Abdelrahim
    Al-masri, Harbi Tomah
    [J]. JOURNAL OF RESEARCH IN PHARMACY, 2024, 28 (05): : 1800 - 1811
  • [7] Main trends in the design of semi-synthetic antibiotics of a new generation
    Olsufyeva, Evgenia N.
    Yankovskaya, Valentina S.
    [J]. RUSSIAN CHEMICAL REVIEWS, 2020, 89 (03) : 339 - 378
  • [8] Design of a novel globular protein fold with atomic-level accuracy
    Kuhlman, B
    Dantas, G
    Ireton, GC
    Varani, G
    Stoddard, BL
    Baker, D
    [J]. SCIENCE, 2003, 302 (5649) : 1364 - 1368
  • [9] Computational design of novel repeat protein families with atomic level accuracy
    Parmeggiani, Fabio
    Brunette, T. J.
    Huang, Po-Ssu
    Ekiert, Damian
    Bhabha, Gira
    Tsutakawa, Susan
    Hura, Greg L.
    Tainer, John A.
    Baker, David
    [J]. PROTEIN SCIENCE, 2016, 25 : 66 - 66
  • [10] Marine Antimicrobial Peptides: A Promising Source of New Generation Antibiotics and Other Bio-active Molecules
    Bertrand, Brandt
    Munoz-Garay, Carlos
    [J]. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2019, 25 (04) : 1441 - 1450